Cargando…

The prevalence, characteristics, and determinants of anaemia in newly diagnosed patients with inflammatory bowel disease

INTRODUCTION: Anaemia is the most common extraintestinal manifestation of inflammatory bowel disease, which has a negative impact on quality of life. AIM: To determinate the prevalence, risk factors, and aetiology of anaemia in newly diagnosed patients with inflammatory bowel disease (IBD). Material...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woźniak, Małgorzata, Barańska, Magdalena, Małecka-Panas, Ewa, Talar-Wojnarowska, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2019
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444104/ https://www.ncbi.nlm.nih.gov/pubmed/30944676 http://dx.doi.org/10.5114/pg.2019.83424

Ejemplares similares

Clinical and Laboratory Characteristics of Anaemia in Hospitalized Patients with Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023)

Leukocytapheresis in patients with inflammatory bowel diseases
por: Woźniak, Małgorzata, et al.
Publicado: (2021)

Procoagulant Disorders in Patients with Newly Diagnosed Pancreatic Adenocarcinoma
por: Talar-Wojnarowska, Renata, et al.
Publicado: (2020)

Determinants of Sleep Quality in Inflammatory Bowel Diseases
por: Sochal, Marcin, et al.
Publicado: (2020)

Clinical Significance of Erythroferrone and Bone Morphogenetic Protein-6 in Patients with Anemia in the Course of Inflammatory Bowel Disease
por: Woźniak, Małgorzata, et al.
Publicado: (2023)

Subclinical Inflammation and Endothelial Dysfunction in Patients with Chronic Pancreatitis and Newly Diagnosed Pancreatic Cancer
por: Gasiorowska, A., et al.
Publicado: (2015)

Association between brain-derived neurotrophic factor and symptoms of insomnia and depression in inflammatory bowel disease (IBD) patients
por: Sochal, M., et al.
Publicado: (2021)

Insulin, insulin-like growth factor 1 and insulin-like growth factor binding protein 3 serum concentrations in patients with adenomatous colon polyps
por: Janiak, Adam, et al.
Publicado: (2013)

Efficiency and safety of one-year anti-TNF-α treatment in Crohn’s disease: a Polish single-centre experience
por: Sochal, Marcin, et al.
Publicado: (2019)

Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy
por: Sochal, Marcin, et al.
Publicado: (2021)

The Prevalence of Cationic Trypsinogen (PRSS1) and Serine Protease Inhibitor, Kazal Type 1 (SPINK1) Gene Mutations in Polish Patients with Alcoholic and Idiopathic Chronic Pancreatitis
por: Gasiorowska, Anita, et al.
Publicado: (2010)

The Effect of Serotonin Transmission on Depressive and Insomnia Symptoms in Inflammatory Bowel Diseases
por: Sochal, Marcin, et al.
Publicado: (2023)

The estimation of metaloproteinases and their inhibitors blood levels in patients with pancreatic tumors
por: Śmigielski, Jacek, et al.
Publicado: (2013)

Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations
por: Kaniewska, Magdalena, et al.
Publicado: (2014)

Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
por: Sochal, Marcin, et al.
Publicado: (2023)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
por: Dudek, Patrycja, et al.
Publicado: (2021)

CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation
por: Wlodarczyk, Barbara, et al.
Publicado: (2023)

Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions
por: TALAR-WOJNAROWSKA, RENATA, et al.
Publicado: (2013)

Quality of life and depression in patients with irritable bowel syndrome
por: Kopczyńska, Magdalena, et al.
Publicado: (2018)

The prevalence of celiac disease in patients with irritable bowel syndrome and its subtypes
por: Domżał-Magrowska, Danuta, et al.
Publicado: (2016)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

The Association between Temperament, Chronotype, Depressive Symptoms, and Disease Activity among Patients with Inflammatory Bowel Disease—A Cross-Sectional Pilot Study
por: Mokros, Łukasz, et al.
Publicado: (2021)

Management of acute pancreatitis (AP) – Polish Pancreatic Club recommendations
por: Rosołowski, Mariusz, et al.
Publicado: (2016)

Dietary Interventions in Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2022)

Sex- and Age-Related Estrogen Signaling Alteration in Inflammatory Bowel Diseases: Modulatory Role of Estrogen Receptors
por: Jacenik, Damian, et al.
Publicado: (2019)

Diagnostic and therapeutic recommendations for chronic pancreatitis. Recommendations of the Working Group of the Polish Society of Gastroenterology and the Polish Pancreas Club
por: Kadaj-Lipka, Roland, et al.
Publicado: (2018)

Dietary Behaviors and Beliefs in Patients with Inflammatory Bowel Disease
por: Godala, Małgorzata, et al.
Publicado: (2023)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
por: Winter, Katarzyna, et al.
Publicado: (2019)

Paneth cell metaplasia in newly diagnosed inflammatory bowel disease in children
por: Simmonds, Naomi, et al.
Publicado: (2014)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients
por: Thorkildsen, Lill Therese, et al.
Publicado: (2013)

Biosimilar medicines – their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in Gastroenterology
por: Mularczyk, Aldona, et al.
Publicado: (2014)

Evaluation of Albumin, Transferrin and Transthyretin in Inflammatory Bowel Disease Patients as Disease Activity and Nutritional Status Biomarkers
por: Godala, Małgorzata, et al.
Publicado: (2023)

Guidelines on the management of irritable bowel syndrome: In memory of Professor Witold Bartnik
por: Pietrzak, Anna, et al.
Publicado: (2018)

Lifestyle Modifications and Colorectal Cancer
por: Durko, Lukasz, et al.
Publicado: (2014)

Time-to-reach Target Calprotectin Level in Newly Diagnosed Patients With Inflammatory Bowel Disease
por: Haisma, Sjoukje-Marije, et al.
Publicado: (2019)

Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease
por: Yin, Yi, et al.
Publicado: (2022)

Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease
por: Nielsen, Ole Haagen, et al.
Publicado: (2018)

Incidence, prevalence and clinical outcome of anaemia in inflammatory bowel disease: a population‐based cohort study
por: Eriksson, Carl, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_arlmdbq9h0eru31ln5su52a5bg